Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mathew Sulecki"'
Autor:
Ahmad A. Tarhini, Mathew Sulecki, Suzanne Lentzsch, L. Pietragallo, Diana Lenzner, Patricia Kropf, Stanley M. Marks, Dhaval R. Mehta, Kenneth A. Foon, Michael Boyiadzis
Publikováno v:
Blood. 119(13)
To the editor: Chemoimmunotherapy with fludarabine (F), cyclophosphamide (C), and rituximab (R) is currently considered the gold standard first-line therapy for chronic lymphocytic leukemia (CLL).[1][1] In an attempt to reduce the neutropenia and mai
Autor:
Stanley M. Marks, Diana Lenzer, Ahmad A. Tarhini, L. Pietragallo, Anastasios Raptis, Mathew Sulecki, P.M. Schaefer, D. Meisner, Michael Boyiadzis, Stephanie R. Land, Andrew D. Laman, Kenneth A. Foon, Allyson R. Butchko
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(4)
Purpose Chemoimmunotherapy combining fludarabine, cyclophosphamide, and rituximab (FCR) is an active regimen for untreated patients with chronic lymphocytic leukemia (CLL) with 70% complete responses (CRs) and 95% overall responses (ORs). However, gr